Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Benzoylformic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100376681C details a microbial asymmetric reduction method for (R)-mandelic acid using Saccharomyces cerevisiae, offering a green, cost-effective alternative to traditional chemical resolution for pharmaceutical manufacturing.
Novel dichromate oxidation method for benzoylformic acid derivatives. High yield, low toxicity, scalable process for pharmaceutical intermediates.
Novel copper-catalyzed decarboxylative acylation method offers mild conditions and high yields for reliable pharmaceutical intermediate supply chains.
Patent CN109499618B reveals a green gas-phase oxidation catalyst for benzoylformic acid, offering significant cost reduction in pharmaceutical intermediates manufacturing and zero waste discharge.